Expert Insights on Pharmaceutical Industry
The Pharmaceutical Industry is the business sector typically encompassing the production and use of small molecule drugs derived from chemical sources. These substances are aimed at treating, curing, preventing, or recognizing disease.
Gerson Lehrman Group Council Members are available to discuss Pharmaceutical Industry via phone consultations, live meetings, surveys, and other custom GLG products and services.
Find, engage, and manageSM experts today through the GLG platform
Featured Council Members
GLG Council Members are leading experts including academics, scientists, and industry specialists
-
Kuldeepak Sharma, PhD
President/Pharmaceutical ConsultantDr. Kuldeepak Sharma
-
Gregory Glover
PartnerPharmaceutical Law Group PC
-
Mark Capriani, MBA
President and Chief Executive OfficerACIES HEALTH INC
-
Alexey Cherpakov
Marketing directorRaifarm
-
Nailesh Bhatt
Managing DirectorPROXIMARE INC
Study Groups
Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry
Recent Live Meetings
Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings
-
May 22, 2009 | Webcast
GLG Webcast: Consolidation Trends - China Pharma on May 22, 2009 at 7:30AM ET
Recent News Analyses
News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations
-
Sandoz’ Generic Drug Push in Japan: Good Timing; Interesting Challenges
October 7, 2009
Sandoz Plans to Sell More Drugs in Japan, May Acquire Companies | www.bloomberg.com
Novartis AG's generic pharmaceutical unit, Sandoz AG's timing for entry into the Japanese pharmaceutical market is excellent as seismic forces in the market make generic drugs more attractive than ever. Sandoz CEO Jeff George's challenges include a prestige-driven hospital system and a private practice/physician...
-
India is a good clinical trial destination with new CROs in future
September 27, 2009
Growing pharma market makes India a clinical trial destination: Report | www.thehindubusinessline.com
Pharmaceutical boom in India has opened up the doors of new clinical trials due to various factors, like new research & treatment avenues, which can be explored best in Indian Clinical Trials due to ease of carrying out Clinical trials in india, which is also giving birth to new CROs.
-
Electronic Health Record Data will be an Industry Gold Mine
October 2, 2009
Survey Highights Power, Limits of EHR Data | www.healthdatamanagement.com
The real value of getting everybody on an electronic medical record in the next decade will not be realized until the data produced through this transition become easily accessible and analyzable to identify, implement and continuously improve best practices. More than three quarters of 732 surveyed...